Bioray Pharmaceutical Co., Ltd.

This is the first time a new drug called BR115 is being tested in people. The main goal is to check its safety and see how the body handles it in 120 patients with advanced solid cancers that have progressed despite standard care. Researchers will also look for any early signs th…

This study is testing if a new drug called HS627 works as well as the standard drug pertuzumab when combined with other treatments before surgery for early or locally advanced HER2-positive breast cancer. The goal is to shrink or eliminate the tumor before the operation. About 40…

This study is testing a new drug called Zuberitamab (HS006) for people with primary membranous nephropathy, a serious autoimmune kidney disease that causes protein loss. It will compare Zuberitamab to an existing drug, cyclosporine, to see which is better at reducing protein in t…